Suggestions
Katherine Lancman
Consumer Brands and Investment
Katherine Lancman is an experienced investor, marketer, and innovation consultant with a focus on high-growth, technology-backed companies.1 She is currently an Investor at Parallel Health, based in California, United States.2
Professional Background
Katherine has a diverse background in consumer brands, marketing, and investment. Her areas of expertise include:
- Direct-to-consumer (DTC) startups
- Microbiome products and technology
- Consumer and health industries
- Finding new market opportunities
Current Roles and Investments
Katherine is actively involved in several roles:
- Investor at Parallel Health
- Marketing & DTC at Hume Supernatural
- Investor at OLIPOP PBC and Blendid
Previous Experience
Her professional history includes positions such as:
- New Ventures at SC Johnson
- Manager, Consumer Innovation at Cerebos
- Account Director for CPG & Health Innovation at Colmar Brunton
- Manager for CPG Brand & Marketing accounts at The Marketing Store, North America
- Innovation and Growth Consultant at RAW Innovation pty limited
Education
Katherine's educational background includes:
- Bachelor of Commerce and Bachelor of Arts in Marketing and Psychology from the University of Melbourne
- Science of Decision Making studies at Stanford University
- Post Graduate Certificate in Advertising from the University of Technology Sydney
Skills and Specialties
Katherine is known for her expertise in:
- Finding new market opportunities
- DTC (Direct-to-Consumer) strategies
- Microbiome industry
- Startup ecosystems
- Consumer and health sectors1
Katherine Lancman is described as an excellent communicator who can effectively work in the space between startups and large companies. Her Twitter bio also mentions that she's a proud Australian.3
Highlights
If you’ve been following the top 20 at TechCrunch Disrupt this week, and interested in the future of precision health and bio hacking, here’s a link to Parallel Health on Centre stage.
Co-founders Natalise Kalea Robinson and Nathan Brown talk antimicrobial resistance, Parallel’s tech stack, personalized reports and skin analytics that all our customers receive…. Alongside the future applications potential of our tech platform.
Plus- a world first live cross to our labs to check out the bio banks and phage manufacturing in process. 🧬
Are you interested in the future of skin health? Or struggling with premature aging and skin inflammation? The secret to your best skin might be hiding in your microbiome 🌱
#techcrunchdisrupt #digitalhealth
Welcoming my LinkedIn network to make a virtual stop at the Parallel Health table D7 at Tech Crunch disrupt today. What a moment. Pure joy. About a month ago Nathan Brown and Natalise Kalea Robinson found out Parallel had been selected in the top 200 companies. This morning, we found out they will be pitching off as part of the top 20 on Wednesday. If you’re keen to try out our first product set (custom skin system to keep your skin ageing well), our show offer includes: -Skin test/Data + 8 skin type analysis
- Phage powered treatment serums
- Balance Restoring Skincare
We are thrilled to have the core technology platform: full genome sequencing, data analytics, robotics, ai, recognized by TechCrunch for the role it can play in human health, ageing and disease. #techcrunchdisrupt #ai #wholegenome #microbiome https://lnkd.in/gwE2kfkj
